Lv31
296 积分 2024-09-24 加入
进步！进步！进步！
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
4小时前
已完结
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
4小时前
已完结
Comparison of a short versus long-course antibiotic therapy for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials
12天前
已完结
Combination of Anti–PD-1 and Electroacupuncture Induces a Potent Antitumor Immune Response in Microsatellite-Stable Colorectal Cancer
20天前
已完结
Mechanisms of postoperative ileus
25天前
已完结
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
25天前
已完结
Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer
25天前
已完结
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
25天前
已完结
Mast Cells in Neuroimmune Interactions
26天前
已完结
皖公网安备34019202002308
